ATS 2019 Virtual Final Program

P438 Cryo Transbronchial Lung Biopsy Vs Forceps Biopsy - Diagnostic Yield and Safety in Interstitial Lung Diseases and Lung Malignancies/ U.C. Shah, A.C. Shah, C.M. Shah, Vadodara, India, p.A1400 P439 Safety and Utility of Transbronchial Lung Cryobiopsy in Mechanically Ventilated Patients with ARDS/ J. Cooley, Z.G. Swank, A. Aragaki Nakahodo, S. Benzaquen, Aurora, CO, p.A1401 Facilitator : S. Benzaquen, MD, ATSF, Cincinnati, OH P440 Bronchoscopic Thermoablative Techniques to Stabilize Excessive Central Airway Collapse: An Ex Vivo Pilot Study on Sheep Tracheal Tissue/ D. Ospina-Delgado, B. Vidal, F. Kheir, A. de Lima, P.A. VanderLaan, S.P. Gangadharan, A. Majid, Boston, MA, p.A1402 P441 Outcomes in Patients Undergoing Thoracentesis with Concomitant Anti-Platelet Therapy / D. Ospina-Delgado, F. Kheir, R. Martinez, M.S. Parikh, A.C. Chee, A. Majid, Boston, MA, p.A1403 P442 First in Human Experience of Placement of a New Size Endobronchial Valve in Patients with Advanced Emphysema/ K. Klooster, T.D. Koster, M. van Dijk, D.-J. Slebos, Groningen, Netherlands, p.A1404 P443 Evaluation of a Low Cost, Re-Useable, Bronchoscopy Biosimulator with Ventilated Lungs: The Bronchoscopy BioSim/ J. Garner, S. Garner, R. Hardie, I. Meireles, C. Caneja, E.D. Tenda, K. Srikanthan, C. Orton, A. Aboelhassan, L. Finney, D. Wiseman, P.L. Molyneaux, M.R. Loebinger, N.S. Hopkinson, S. Kemp, P.L. Shah, London, United Kingdom, p.A1405 P444 Trends in Endobronchial Valve Implantation and Associated In-Hospital Complications in Patients with Persistent Air Leak: Analysis of a Nationwide Database Over a 10-Year Period/ S.-W. Low, J.Z. Lee, R. Cartin-Ceba, L.J. Wesselius, L.T. Vaszar, K.L. Swanson, K.K. Sakata, Scottsdale, AZ, p.A1406 P445 Argon Plasma Electrosurgery: Mechanism of Injury Causing Gas Embolism/ C. Oberg, S. Fernandez-Bussy, A.C. Mehta, A. Majid, E.E. Folch, Boston, MA, p.A1407 P446 Sensitivity Off Radial Endobronchial Ultrasound Guided Bronchoscopy for Lung Cancer in Patients with Lung Nodules: An Updated Meta-Analysis/ P. Sainz Zuñiga, E. Vakil, S. Molina, D.E. Ost, Houston, TX, p.A1408 P447 Use of a Novel Non-Invasive Ventilation Unit in Patients with Excessive Dynamic Airway Collapse/ E. Backer, Lebanon, NH, p.A1409 P448 Radial Endobronchial Ultrasound Guided Bronchoscopic Cryobiopsy Without Fluoroscopy for Peripheral Lung Lesions and Interstitial Lung Diseases/ W.-C. Cheng, M.-F. Shen, B.-R. Wu, C.-Y. Chen, W.-C. Chen, W.-C. Liao, C.-H. Chen, C.-Y. Tu, Taichung, Taiwan, p.A1410 P449 Novel Experience of High Frequency Jet Ventilation Technique in Non Intubated Sedated Patients Via the Working Channel of Flexible Bronchoscope/ A. Abedini, A. Kiani, K. Taghavi, A. Khalili, B. Farzanegan, Tehran, Iran, Islamic Republic of, p.A1411 BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION A36 RARE LUNG DISEASES FROM BENCH TO BEDSIDE 9:15 a.m. - 4:15 p.m. KBHCCD Area D (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitators : W.A. Bulman, MD, New York, NY M. Iikura, MD, PhD, Tokyo, Japa P451 Menstrual Cycle-Related Symptom Variability in Patients with Lymphangioleiomyomatosis/ B. Shaw, E.J.-A. Kopras, N. Gupta, Cincinnati, OH, p.A1412 P452 Single Center Experience of Lung transplantation for Lymphangioleiomyomatosis/ J. Zhang, Wuxi, China, p.A1413 P453 Prognostic Impacts of Comorbidities in Pulmonary Alveolar Proteinosis: A Nationwide Surveillance in Japan/ Y. Inoue, E. Yamaguchi, Y. Setoguchi, T. Ichiwata, M. Ebina, K. Cho, R. Tazawa, H. Ishii, T. Kasai, M. Akira, T. Arai, K. Uchida, H. Kida, K. Morimoto, M. Kitaichi, K. Hatsuda, C. Sugimoto, M. Hirose, K. Nakata, Osaka, Japan, p.A1414 P454 Thoracic Paravertebral Lesions in Patients with IgG4-Related Respiratory Disease/ S. Matsui, S. Okazawa, K. Tokui, K. Kambara, S. Imanishi, K. Shimokawa, T. Hirai, M. Inomata, T. Miwa, R. Hayashi, K. Tobe, Toyama-shi, Toyama, Japan, p.A1415 P455 Change of Pulmonary Function Test in Patients with Tuberous Sclerosis Complex - Lymphangioleiomyomatosis (TSC-LAM)/ L.-C. Chen, Y.-W. Kuo, P.-H. Kuo, H.-D. Wu, H.-C. Wang, Taipei City, Taiwan, p.A1416 P456 An Approach to Precision Medicine for Pulmonary Alveolar Proteinosis/ E. Lee, C. McCarthy, J.P. Bridges, J.C. Woods, T. Suzuki, B.C. Carey, T.S. Wang, B.C. Trapnell, E.J. Tarling, Los Angeles, CA, p.A1417 Facilitator : A.S. Kristof, MD, Montreal, Canada P457 Lymphangioleiomyomatosis (LAM) Nodules Attract and Activate Alveolar Type II Cells/ D. Clements, R. Babaei-Jadidi, S. Miller, S.R. Johnson, Nottingham, United Kingdom, p.A1418 P458 Serum VEGF-D Level in the Periods of Not Taking mTOR Inhibitors in the Patients with Lymphangioleiomyomatosis/ M. Hirose, T. Arai, C. Sugimoto, T. Takimoto, Y. Inoue, Osaka, Japan, p.A1419 P459 Exosomes Released from Lymphangioleiomyomatosis-Derived Smooth Muscle-Like Cells Mediate Endothelial Cell Apoptosis and Vascular Network Disruption/ M. Ho, M. Ho, L. Julian, W. Stanford, D.J. Stewart, Ottawa, Canada, p.A1420 P460 Mast Cell Recruitment in Lymphangiomatosis and Lung Cystic Destruction; Opportunities for Drug Repurposing/ R. Babaei Jadidi, A. Dongre, D. Clements, S. Miller, S. Johnson, Nottingham, United Kingdom, p.A1421 ATS 2019 • Dallas, TX SUNDAY • MAY 19 51 SUNDAY MORNING